{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "Drug molecules", "Medicinal plants", "Middle Eastern Respiratory Syndrome (MERS).", "Plant-based antivirals", "SARS-CoV-2"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38477206", "DateCompleted": {"Year": "2024", "Month": "05", "Day": "30"}, "DateRevised": {"Year": "2024", "Month": "05", "Day": "31"}, "Article": {"Language": ["eng"], "ELocationID": ["10.2174/0115680266276749240206101847"], "ArticleDate": [], "Journal": {"ISSN": "1873-4294", "JournalIssue": {"Volume": "24", "Issue": "7", "PubDate": {"Year": "2024"}}, "Title": "Current topics in medicinal chemistry", "ISOAbbreviation": "Curr Top Med Chem"}, "ArticleTitle": "Repurposing of Plant-based Antiviral Molecules for the Treatment of COVID-19.", "Pagination": {"StartPage": "614", "EndPage": "633", "MedlinePgn": "614-633"}, "Abstract": {"AbstractText": ["COVID-19, stemming from SARS-CoV-2, poses a formidable threat to global healthcare, with a staggering 77 million confirmed cases and 690,067 deaths recorded till December 24, 2023. Given the absence of specific drugs for this viral infection, the exploration of novel antiviral compounds becomes imperative. High-throughput technologies are actively engaged in drug discovery, and there is a parallel effort to repurpose plant-based molecules with established antiviral properties. In this context, the review meticulously delves into the potential of plant-based folk remedies and existing molecules. These substances have showcased substantial viral inhibition in diverse <i>in vivo, in silico</i>, and <i>in vitro</i> studies, particularly against critical viral protein targets, including SARS-CoV-2. The findings position these plant-based molecules as promising antiviral drug candidates for the swift advancement of treatments for COVID-19. It is noteworthy that the inherent attributes of these plant-based molecules, such as their natural origin, potency, safety, and cost-effectiveness, contribute to their appeal as lead candidates. The review advocates for further exploration through comprehensive in vivo studies conducted on animal models, emphasizing the potential of plant-based compounds to help in the ongoing quest to develop effective antivirals against COVID-19."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, HKM Govt. Degree College Eidgah, Cluster University Srinagar, J&K, 190001, India."}], "LastName": "Khazir", "ForeName": "Jabeena", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Indian Institute of Integrative Medicine, Canal Road Jammu, 180001, J&K, India."}], "LastName": "Ahmed", "ForeName": "Sajad", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Amity Institute of Biotechnology, Amity University, Noida, 201313, India."}], "LastName": "Thakur", "ForeName": "Rakesh Kr", "Initials": "RK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Botanical and Environmental Sciences, Guru Nanak Dev University, Amritsar, 143005, Punjab, India."}, {"Identifier": [], "Affiliation": "Department of Botany, North Campus, University of Kashmir, Delina, Baramulla, J&K, 193103, India."}], "LastName": "Hussain", "ForeName": "Manzoor", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Indian Institute of Integrative Medicine, Canal Road Jammu, 180001, J&K, India."}], "LastName": "Gandhi", "ForeName": "Sumit G", "Initials": "SG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Botany, Swami Shradhanand College, University of Delhi, Delhi, 110036, India."}], "LastName": "Babbar", "ForeName": "Sadhana", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratory Sciences, College of Applied Medical Science, Majmaah University, Al Majmaah, 11952, Saudi Arabia."}], "LastName": "Mir", "ForeName": "Shabir Ahmad", "Initials": "SA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, HKM Govt. Degree College Eidgah, Cluster University Srinagar, J&K, 190001, India."}], "LastName": "Shafi", "ForeName": "Nusrat", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Biotechnology and Environment, Department of Plant Biology, Faculty of Science, University of Yaounde I, PO Box 812, Yaounde, Cameroon."}], "LastName": "Tonfack", "ForeName": "Libert Brice", "Initials": "LB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Botany, Hans Raj College, University of Delhi, Delhi, 110007, India."}], "LastName": "Rajpal", "ForeName": "Vijay Rani", "Initials": "VR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanotherapeutics and Regenerative Medicine, University of Kashmir, Srinagar, 190006, India."}], "LastName": "Maqbool", "ForeName": "Tariq", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Botany, North Campus, University of Kashmir, Delina, Baramulla, J&K, 193103, India."}], "LastName": "Mir", "ForeName": "Bilal Ahmad", "Initials": "BA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Botany, University of Kashmir, Srinagar, J&K, 190006, India."}], "LastName": "Peer", "ForeName": "Latif Ahmad", "Initials": "LA"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Curr Top Med Chem", "NlmUniqueID": "101119673", "ISSNLinking": "1568-0266"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "chemistry", "therapeutic use"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}, {"QualifierName": [], "DescriptorName": "Drug Repositioning"}, {"QualifierName": ["drug effects"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["virology"], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Animals"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Moriyama M.; Hugentobler W.J.; Iwasaki A.; Seasonality of respiratory viral infections. Annu Rev Virol 2020,7(1),83-101", "ArticleIdList": ["10.1146/annurev-virology-012420-022445", "32196426"]}, {"Citation": "Groneberg D.A.; Hilgenfeld R.; Zabel P.; Molecular mechanisms of severe acute respiratory syndrome (SARS). Respir Res 2005,6(1),8", "ArticleIdList": ["10.1186/1465-9921-6-8", "15661082"]}, {"Citation": "Lee N.; Hui D.; Wu A.; Chan P.; Cameron P.; Joynt G.M.; Ahuja A.; Yung M.Y.; Leung C.B.; To K.F.; Lui S.F.; Szeto C.C.; Chung S.; Sung J.J.Y.; A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003,348(20),1986-1994", "ArticleIdList": ["10.1056/NEJMoa030685", "12682352"]}, {"Citation": "Cheng V.C.C.; Lau S.K.P.; Woo P.C.Y.; Yuen K.Y.; Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev 2007,20(4),660-694", "ArticleIdList": ["10.1128/CMR.00023-07", "17934078"]}, {"Citation": "Zaki A.M.; van Boheemen S.; Bestebroer T.M.; Osterhaus A.D.M.E.; Fouchier R.A.M.; Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012,367(19),1814-1820", "ArticleIdList": ["10.1056/NEJMoa1211721", "23075143"]}, {"Citation": "Cui J.; Li F.; Shi Z.L.; Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019,17(3),181-192", "ArticleIdList": ["10.1038/s41579-018-0118-9", "30531947"]}, {"Citation": "Paules C.I.; Marston H.D.; Fauci A.S.; Coronavirus infections-More than just the common cold. JAMA 2020,323(8),707-708", "ArticleIdList": ["10.1001/jama.2020.0757", "31971553"]}, {"Citation": "Lau S.K.P.; Woo P.C.Y.; Li K.S.M.; Huang Y.; Tsoi H.W.; Wong B.H.L.; Wong S.S.Y.; Leung S.Y.; Chan K.H.; Yuen K.Y.; Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad Sci 2005,102(39),14040-14045", "ArticleIdList": ["10.1073/pnas.0506735102", "16169905"]}, {"Citation": "Reusken C.B.E.M.; Haagmans B.L.; M\u00fcller M.A.; Gutierrez C.; Godeke G.J.; Meyer B.; Muth D.; Raj V.S.; Vries L.S-D.; Corman V.M.; Drexler J.F.; Smits S.L.; El Tahir Y.E.; De Sousa R.; van Beek J.; Nowotny N.; van Maanen K.; Hidalgo-Hermoso E.; Bosch B.J.; Rottier P.; Osterhaus A.; Gort\u00e1zar-Schmidt C.; Drosten C.; Koopmans M.P.G.; Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: A comparative serological study. Lancet Infect Dis 2013,13(10),859-866", "ArticleIdList": ["10.1016/S1473-3099(13)70164-6", "23933067"]}, {"Citation": "de Wit E.; van Doremalen N.; Falzarano D.; Munster V.J.; SARS and MERS: Recent insights into emerging coronaviruses. Nat Rev Microbiol 2016,14(8),523-534", "ArticleIdList": ["10.1038/nrmicro.2016.81", "27344959"]}, {"Citation": "Enmozhi S.K.; Raja K.; Sebastine I.; Joseph J.; Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: An in silico approach. J Biomol Struct Dyn 2021,39(9),3092-3098", "ArticleIdList": ["32329419"]}, {"Citation": "Gorbalenya A.E.; Baker S.C.; Baric R.S.; de Groot R.J.; Drosten C.; Gulyaeva A.A.; Haagmans B.L.; Lauber C.; Leontovich A.M.; Neuman B.W.; Penzar D.; Perlman S.; Poon L.L.M.; Samborskiy D.V.; Sidorov I.A.; Sola I.; Ziebuhr J.; The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020,5(4),536-544", "ArticleIdList": ["10.1038/s41564-020-0695-z", "32123347"]}, {"Citation": "York A.; Novel coronavirus takes flight from bats? Nat Rev Microbiol 2020,18(4),191-191", "ArticleIdList": ["10.1038/s41579-020-0336-9", "32051570"]}, {"Citation": "Zhou P.; Yang X.-L.; Wang X.-G.; Hu B.; Zhang L.; Zhang W.; Si H.-R.; Zhu Y.; Li B.; Huang C.-L.; A pneumonia outbreak associated with a new coronavirus of probable bat origin. nature 2020,579,270-273"}, {"Citation": "Cucinotta D.; Vanelli M.; WHO declares COVID-19 a pandemic. Acta Biomed 2020,91(1),157-160", "ArticleIdList": ["32191675"]}, {"Citation": "Rajpal V.R.; Sharma S.; Sehgal D.; Singh A.; Kumar A.; Vaishnavi S.; Tiwari M.; Bhalla H.; Goel S.; Raina S.N.; A comprehensive account of SARS-CoV-2 genome structure, incurred mutations, lineages and COVID-19 vaccination program. Future Virol 2022,17(9),687-706", "ArticleIdList": ["10.2217/fvl-2021-0277", "35747328"]}, {"Citation": "Rajpal V.R.; Sharma S.; Kumar A.; Chand S.; Joshi L.; Chandra A.; Babbar S.; Goel S.; Raina S.N.; Shiran B.; \u201cIs Omicron mild\u201d? Testing this narrative with the mutational landscape of its three lineages and response to existing vaccines and therapeutic antibodies. J Med Virol 2022,94(8),3521-3539", "ArticleIdList": ["10.1002/jmv.27749", "35355267"]}, {"Citation": "Rajpal V.R.; Sharma S.; Kumar A.; Vaishnavi S.; Singh A.; Sehgal D.; Tiwari M.; Goel S.; Raina S.N.; Mapping of SARS-CoV-2 spike protein evolution during the first and second waves of COVID-19 infections in India. Future Virol 2022,17(8),557-575", "ArticleIdList": ["10.2217/fvl-2021-0267", "35747327"]}, {"Citation": "Ashburn T.T.; Thor K.B.; Drug repositioning: Identifying and developing new uses for existing drugs. Nat Rev Drug Discov 2004,3(8),673-683", "ArticleIdList": ["10.1038/nrd1468", "15286734"]}, {"Citation": "Kruse R.L.; Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China. F1000 Res 2020,9,72", "ArticleIdList": ["10.12688/f1000research.22211.2", "32117569"]}, {"Citation": "Morse J.S.; Lalonde T.; Xu S.; Liu W.R.; Learning from the past: Possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019\u2010nCoV. ChemBioChem 2020,21(5),730-738", "ArticleIdList": ["10.1002/cbic.202000047", "32022370"]}, {"Citation": "Li G.; De Clercq E.; Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov 2020,19(3),149-150", "ArticleIdList": ["10.1038/d41573-020-00016-0", "32127666"]}, {"Citation": "Kupferschmidt K.; Cohen J.; Race to find COVID-19 treatments accelerates. Science 2020,367(6485),1412-1413", "ArticleIdList": ["10.1126/science.367.6485.1412"]}, {"Citation": "Kivrak A.;; Ula\u015f, B.; Kivrak, H. A comparative analysis for anti-viral drugs: Their efficiency against SARS-CoV-2. Int Immunopharmacol 2021,90,107232", "ArticleIdList": ["10.1016/j.intimp.2020.107232", "33290969"]}, {"Citation": "Cecon E.; Izabelle C.; Poder S.L.; Real F.; Zhu A.; Tu L.; Ghigna M.R.; Klonjkowski B.; Bomsel M.; Jockers R.; Dam J.; Therapeutic potential of melatonin and melatonergic drugs on K18\u2010 hACE2 mice infected with SARS\u2010CoV\u20102. J Pineal Res 2022,72(1),e12772", "ArticleIdList": ["10.1111/jpi.12772", "34586649"]}, {"Citation": "Huang J.; Tao G.; Liu J.; Cai J.; Huang Z.; Chen J.; Current prevention of COVID-19: Natural products and herbal medicine. Front Pharmacol 2020,11,588508", "ArticleIdList": ["10.3389/fphar.2020.588508", "33178026"]}, {"Citation": "Lu H.; Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends 2020,14(1),69-71", "ArticleIdList": ["10.5582/bst.2020.01020", "31996494"]}, {"Citation": "Bauso L.; Imbesi C.; Irene G.; Cal\u00ec G.; Bitto A.; New approaches and repurposed antiviral drugs for the treatment of the SARSCoV-2 infection. Pharmaceuticals 2021,14(6),503", "ArticleIdList": ["10.3390/ph14060503", "34070359"]}, {"Citation": "Chakravarti R.; Singh R.; Ghosh A.; Dey D.; Sharma P.; Velayutham R.; Roy S.; Ghosh D.; A review on potential of natural products in the management of COVID-19. RSC Advances 2021,11(27),16711-16735", "ArticleIdList": ["10.1039/D1RA00644D", "35479175"]}, {"Citation": "Pawe\u0142czyk, A.; Zaprutko, L. Anti-COVID drugs: Repurposing existing drugs or search for new complex entities, strategies and perspectives. Future Med Chem 2020,12(19),1743-1757", "ArticleIdList": ["10.4155/fmc-2020-0204", "32698626"]}, {"Citation": "Khan T.; Khan M.A.; Mashwani Z.R.; Ullah N.; Nadhman A.; Therapeutic potential of medicinal plants against COVID-19: The role of antiviral medicinal metabolites. Biocatal Agric Biotechnol 2021,31,101890", "ArticleIdList": ["10.1016/j.bcab.2020.101890", "33520034"]}, {"Citation": "Wijayasinghe Y.S.; Bhansali P.; Viola R.E.; Kamal M.A.; Poddar N.K.; Natural products: A rich source of antiviral drug lead candidates for the management of COVID-19. Curr Pharm Des 2021,27(33),3526-3550", "ArticleIdList": ["10.2174/18734286MTEx6NjI23", "33213322"]}, {"Citation": "Junior A.G.; Tolouei S.E.L.; Dos Reis L\u00edvero F.A.; Gasparotto F.; Boeing T.; de Souza P.; Natural agents modulating ACE-2: A review of compounds with potential against SARS-CoV-2 infections. Curr Pharm Des 2021,27(13),1588-1596", "ArticleIdList": ["10.2174/18734286MTEzvMzMcw", "33459225"]}, {"Citation": "Jeon S.; Ko M.; Lee J.; Choi I.; Byun S.Y.; Park S.; Shum D.; Kim S.; Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs. Antimicrob Agents Chemother 2020,64(7),e00819-e00820", "ArticleIdList": ["10.1128/AAC.00819-20", "32366720"]}, {"Citation": "Matsuyama S.; Nagata N.; Shirato K.; Kawase M.; Takeda M.; Taguchi F.; Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J Virol 2010,84(24),12658-12664", "ArticleIdList": ["10.1128/JVI.01542-10", "20926566"]}, {"Citation": "Riva L.; Yuan S.; Yin X.; Martin-Sancho L.; Matsunaga N.; Pache L.; Burgstaller-Muehlbacher S.; De Jesus P.D.; Teriete P.; Hull M.V.; Chang M.W.; Chan J.F.W.; Cao J.; Poon V.K.M.; Herbert K.M.; Cheng K.; Nguyen T.T.H.; Rubanov A.; Pu Y.; Nguyen C.; Choi A.; Rathnasinghe R.; Schotsaert M.; Miorin L.; Dejosez M.; Zwaka T.P.; Sit K.Y.; Martinez-Sobrido L.; Liu W.C.; White K.M.; Chapman M.E.; Lendy E.K.; Glynne R.J.; Albrecht R.; Ruppin E.; Mesecar A.D.; Johnson J.R.; Benner C.; Sun R.; Schultz P.G.; Su A.I.; Garc\u00eda-Sastre A.; Chatterjee A.K.; Yuen K.Y.; Chanda S.K.; Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature 2020,586(7827),113-119", "ArticleIdList": ["10.1038/s41586-020-2577-1", "32707573"]}, {"Citation": "Isidoro C.; Chang A.C.-F.; Sheen L.-Y.; Natural products as a source of novel drugs for treating SARS-CoV2 infection. J Tradit Complement Med 2022,12(1),1-5", "ArticleIdList": ["10.1016/j.jtcme.2022.02.001"]}, {"Citation": "Hensel A.; Bauer R.; Heinrich M.; Spiegler V.; Kayser O.; Hempel G.; Kraft K.; Challenges at the time of COVID-19: Opportunities and innovations in antivirals from nature. Planta Med 2020,86(10),659-664", "ArticleIdList": ["10.1055/a-1177-4396", "32434254"]}, {"Citation": "Newman D.J.; Cragg G.M.; Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 2012,75(3),311-335", "ArticleIdList": ["10.1021/np200906s", "22316239"]}, {"Citation": "Cragg G.M.; Grothaus P.G.; Newman D.J.; Impact of natural products on developing new anti-cancer agents. Chem Rev 2009,109(7),3012-3043", "ArticleIdList": ["10.1021/cr900019j", "19422222"]}, {"Citation": "Newman D.J.; Cragg G.M.; Natural products as sources of new drugs from 1981 to 2014. J Nat Prod 2016,79(3),629-661", "ArticleIdList": ["10.1021/acs.jnatprod.5b01055", "26852623"]}, {"Citation": "Benarba B.; Pandiella A.; Medicinal plants as sources of active molecules against COVID-19. Front Pharmacol 2020,11,1189", "ArticleIdList": ["10.3389/fphar.2020.01189", "32848790"]}, {"Citation": "Orhan I.E.; Senol Deniz F.S.; Natural products as potential leads against coronaviruses: Could they be encouraging structural models against SARS-CoV-2? Nat Prod Bioprospect 2020,10(4),171-186", "ArticleIdList": ["10.1007/s13659-020-00250-4", "32529545"]}, {"Citation": "Jahan I.; Onay A.; Potentials of plant-based substance to inhabit and probable cure for the COVID-19. Turk J Biol 2020,44(3),228-241", "ArticleIdList": ["10.3906/biy-2005-114", "32595359"]}, {"Citation": "Mani J.S.; Johnson J.B.; Steel J.C.; Broszczak D.A.; Neilsen P.M.; Walsh K.B.; Naiker M.; Natural product-derived phytochemicals as potential agents against coronaviruses: A review. Virus Res 2020,284,197989", "ArticleIdList": ["10.1016/j.virusres.2020.197989", "32360300"]}, {"Citation": "Merarchi M.; Dudha N.; Das B.C.; Garg M.; Natural products and phytochemicals as potential ANTI\u2010SARS\u2010COV \u20102 drugs. Phytother Res 2021,35(10),5384-5396", "ArticleIdList": ["10.1002/ptr.7151", "34132421"]}, {"Citation": "Adhikari B.; Marasini B.P.; Rayamajhee B.; Bhattarai B.R.; Lamichhane G.; Khadayat K.; Adhikari A.; Khanal S.; Parajuli N.; Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID \u201019: A review. Phytother Res 2021,35(3),1298-1312", "ArticleIdList": ["10.1002/ptr.6893", "33037698"]}, {"Citation": "Musarra-Pizzo M.; Pennisi R.; Ben-Amor I.; Mandalari G.; Sciortino M.T.; Antiviral activity exerted by natural products against human viruses. Viruses 2021,13(5),828", "ArticleIdList": ["10.3390/v13050828", "34064347"]}, {"Citation": "Scotti L.; Lopes S.M.; de Medeiros H.I.R.; Scotti M.T.; Natural products against COVID-19 inflammation: A mini-review. Comb Chem High Throughput Screen 2022,25(14),2358-2369", "ArticleIdList": ["10.2174/1386207325666220128114547", "35088662"]}, {"Citation": "Akram M.; Tahir I.M.; Shah S.M.A.; Mahmood Z.; Altaf A.; Ahmad K.; Munir N.; Daniyal M.; Nasir S.; Mehboob H.; Antiviral potential of medicinal plants against HIV, HSV, influenza, hepatitis, and coxsackievirus: A systematic review. Phytother Res 2018,32(5),811-822", "ArticleIdList": ["10.1002/ptr.6024", "29356205"]}, {"Citation": "Ben-Shabat S.; Yarmolinsky L.; Porat D.; Dahan A.; Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategies. Drug Deliv Transl Res 2020,10(2),354-367", "ArticleIdList": ["10.1007/s13346-019-00691-6", "31788762"]}, {"Citation": "Guo Y.R.; Cao Q.D.; Hong Z.S.; Tan Y.Y.; Chen S.D.; Jin H.J.; Tan K.S.; Wang D.Y.; Yan Y.; The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak \u2013 an update on the status. Mil Med Res 2020,7(1),11", "ArticleIdList": ["10.1186/s40779-020-00240-0"]}, {"Citation": "Pamuru R.R.; Ponneri N.; Damu A.G.; Vadde R.; Targeting natural products for the treatment of COVID-19\u2013an updated review. Curr Pharm Des 2020,26(41),5278-5285", "ArticleIdList": ["10.2174/1381612826666200903122536", "32881659"]}, {"Citation": "Boozari M.; Hosseinzadeh H.; Natural products for COVID \u201019 prevention and treatment regarding to previous coronavirus infections and novel studies. Phytother Res 2021,35(2),864-876", "ArticleIdList": ["10.1002/ptr.6873", "32985017"]}, {"Citation": "Maurya V.K.; Kumar S.; Prasad A.K.; Bhatt M.L.B.; Saxena S.K.; Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor. Virusdisease 2020,31(2),179-193", "ArticleIdList": ["10.1007/s13337-020-00598-8", "32656311"]}, {"Citation": "Li F.; Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol 2016,3(1),237-261", "ArticleIdList": ["10.1146/annurev-virology-110615-042301", "27578435"]}, {"Citation": "Shereen M.A.; Khan S.; Kazmi A.; Bashir N.; Siddique R.; COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses. J Adv Res 2020,24,91-98", "ArticleIdList": ["10.1016/j.jare.2020.03.005", "32257431"]}, {"Citation": "Wu A.; Peng Y.; Huang B.; Ding X.; Wang X.; Niu P.; Meng J.; Zhu Z.; Zhang Z.; Wang J.; Sheng J.; Quan L.; Xia Z.; Tan W.; Cheng G.; Jiang T.; Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe 2020,27(3),325-328", "ArticleIdList": ["10.1016/j.chom.2020.02.001", "32035028"]}, {"Citation": "Huang Y.; Yang C.; Xu X.; Xu W.; Liu S.; Structural and functional properties of SARS-CoV-2 spike protein: Potential antivirus drug development for COVID-19. Acta Pharmacol Sin 2020,41(9),1141-1149", "ArticleIdList": ["10.1038/s41401-020-0485-4", "32747721"]}, {"Citation": "Fehr A.R.; Perlman S.; Coronaviruses: An overview of their replication and pathogenesis. Coronaviruses: methods and protocols 2015,1-23|"}, {"Citation": "Bosch B.J.; van der Zee R.; de Haan C.A.M.; Rottier P.J.M.; The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex. J Virol 2003,77(16),8801-8811", "ArticleIdList": ["10.1128/JVI.77.16.8801-8811.2003", "12885899"]}, {"Citation": "Li F.; Li W.; Farzan M.; Harrison S.C.; Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 2005,309(5742),1864-1868", "ArticleIdList": ["10.1126/science.1116480", "16166518"]}, {"Citation": "Heurich A.; Hofmann-Winkler H.; Gierer S.; Liepold T.; Jahn O.; P\u00f6hlmann S.; TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol 2014,88(2),1293-1307", "ArticleIdList": ["10.1128/JVI.02202-13", "24227843"]}, {"Citation": "Sawicki S.; Sawicki D.; Coronavirus transcription: A perspective. Coronavirus replication and reverse genetics 2005,31-35"}, {"Citation": "Masters P.S.; The molecular biology of coronaviruses. Adv Virus Res 2006,66,193-292", "ArticleIdList": ["10.1016/S0065-3527(06)66005-3", "16877062"]}, {"Citation": "Xu X.; Chen P.; Wang J.; Feng J.; Zhou H.; Li X.; Zhong W.; Hao P.; Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci 2020,63(3),457-460", "ArticleIdList": ["10.1007/s11427-020-1637-5", "32009228"]}, {"Citation": "Kuhn J.H.; Radoshitzky S.R.; Li W.; Wong S.K.; Choe H.; Farzan M.; The SARS Coronavirus receptor ACE 2 A potential target for antiviral therapy 2006,397-418", "ArticleIdList": ["10.1007/978-0-387-31047-3_15"]}, {"Citation": "Naqvi A.A.T.; Fatima K.; Mohammad T.; Fatima U.; Singh I.K.; Singh A.; Atif S.M.; Hariprasad G.; Hasan G.M.; Hassan M.I.; Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach. Biochim Biophys Acta Mol Basis Dis 2020,1866(10),165878", "ArticleIdList": ["10.1016/j.bbadis.2020.165878", "32544429"]}, {"Citation": "Ghildiyal R.; Prakash V.; Chaudhary V.; Gupta V.; Gabrani R.; Phytochemicals as antiviral agents: Recent updates. Plant-derived bioactives: production, properties and therapeutic applications 2020,279-295"}, {"Citation": "Ishfaq M.; Chen C.; Bao J.; Zhang W.; Wu Z.; Wang J.; Liu Y.; Tian E.; Hamid S.; Li R.; Ding L.; Li J.; Baicalin ameliorates oxidative stress and apoptosis by restoring mitochondrial dynamics in the spleen of chickens via the opposite modulation of NF-\u03baB and Nrf2/HO-1 signaling pathway during Mycoplasma gallisepticum infection. Poult Sci 2019,98(12),6296-6310", "ArticleIdList": ["10.3382/ps/pez406", "31376349"]}, {"Citation": "Chen F.; Chan K.H.; Jiang Y.; Kao R.Y.T.; Lu H.T.; Fan K.W.; Cheng V.C.C.; Tsui W.H.W.; Hung I.F.N.; Lee T.S.W.; Guan Y.; Peiris J.S.; Yuen K.Y.; In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J Clin Virol 2004,31(1),69-75", "ArticleIdList": ["10.1016/j.jcv.2004.03.003", "15288617"]}, {"Citation": "Deng Y.F.; Aluko R.E.; Jin Q.; Zhang Y.; Yuan L.J.; Inhibitory activities of baicalin against renin and angiotensinconverting enzyme. Pharm Biol 2012,50(4),401-406", "ArticleIdList": ["10.3109/13880209.2011.608076", "22136493"]}, {"Citation": "Chen H.H.; Du Q.; Potential natural compounds for preventing 2019-nCoV infection 2020,10"}, {"Citation": "Linda Laksmiani N.P.; Febryana Larasanty L.P.; Gde Jaya Santika A.A.; Andika Prayoga P.A.; Intan Kharisma Dewi A.A.; Ayu Kristiara Dewi N.P.; Active compounds activity from the medicinal plants against SARS-CoV-2 using in silico assay. Biomed Pharmacol J 2020,13(2),873-881", "ArticleIdList": ["10.13005/bpj/1953"]}, {"Citation": "Wang D.; Guo H.; Chang J.; Wang D.; Liu B.; Gao P.; Wei W.; Andrographolide prevents EV-D68 replication by inhibiting the acidification of virus-containing endocytic vesicles. Front Microbiol 2018,9,2407", "ArticleIdList": ["10.3389/fmicb.2018.02407", "30349523"]}, {"Citation": "Wang W.; Ma X.; Han J.; Zhou M.; Ren H.; Pan Q.; Zheng C.; Zheng Q.; Neuroprotective effect of scutellarin on ischemic cerebral injury by down-regulating the expression of angiotensin-converting enzyme and AT1 receptor. PLoS One 2016,11(1),e0146197", "ArticleIdList": ["10.1371/journal.pone.0146197", "26730961"]}, {"Citation": "Yu X.; Sun S.; Guo Y.; Liu Y.; Yang D.; Li G.; L\u00fc S.; Citri reticulatae pericarpium (Chenpi): Botany, ethnopharmacology, phytochemistry, and pharmacology of a frequently used traditional chinese medicine. J Ethnopharmacol 2018,220,265-282", "ArticleIdList": ["10.1016/j.jep.2018.03.031", "29628291"]}, {"Citation": "Antonio A.S.; Wiedemann L.S.M.; Veiga-Junior V.F.; Natural products\u2019 role against COVID-19. RSC Advances 2020,10(39),23379-23393", "ArticleIdList": ["10.1039/D0RA03774E", "35693131"]}, {"Citation": "Lin C.W.; Tsai F.J.; Tsai C.H.; Lai C.C.; Wan L.; Ho T.Y.; Hsieh C.C.; Chao P.D.L.; Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Res 2005,68(1),36-42", "ArticleIdList": ["10.1016/j.antiviral.2005.07.002", "16115693"]}, {"Citation": "Zanwar A.A.; Badole S.L.; Shende P.S.; Hegde M.V.; Bodhankar S.L.; Cardiovascular effects of hesperidin: A flavanone glycoside. Polyphenols in human health and disease 2014,989-992", "ArticleIdList": ["10.1016/B978-0-12-398456-2.00076-1"]}, {"Citation": "Jadeja R.N.; Devkar R.V.; Polyphenols and flavonoids in controlling non-alcoholic steatohepatitis. Polyphenols in human health and disease 2014,615-623", "ArticleIdList": ["10.1016/B978-0-12-398456-2.00047-5"]}, {"Citation": "Huang F.; Li Y.; Leung E.L.H.; Liu X.; Liu K.; Wang Q.; Lan Y.; Li X.; Yu H.; Cui L.; Luo H.; Luo L.; A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19). Pharmacol Res 2020,158,104929", "ArticleIdList": ["10.1016/j.phrs.2020.104929", "32442720"]}, {"Citation": "Dong W.; Wei X.; Zhang F.; Hao J.; Huang F.; Zhang C.; Liang W.; A dual character of flavonoids in influenza A virus replication and spread through modulating cell-autonomous immunity by MAPK signaling pathways. Sci Rep 2014,4(1),7237", "ArticleIdList": ["10.1038/srep07237", "25429875"]}, {"Citation": "Ali S.; Alam M.; Khatoon F.; Fatima U.; Elasbali A.M.; Adnan M.; Islam A.; Hassan M.I.; Snoussi M.; De Feo V.; Natural products can be used in therapeutic management of COVID-19: Probable mechanistic insights. Biomed Pharmacother 2022,147,112658", "ArticleIdList": ["10.1016/j.biopha.2022.112658", "35066300"]}, {"Citation": "Cinatl J.; Morgenstern B.; Bauer G.; Chandra P.; Rabenau H.; Doerr H.W.; Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 2003,361(9374),2045-2046", "ArticleIdList": ["10.1016/S0140-6736(03)13615-X", "12814717"]}, {"Citation": "Hoever G.; Baltina L.; Michaelis M.; Kondratenko R.; Baltina L.; Tolstikov G.A.; Doerr H.W.; Cinatl J.; Jr Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus. J Med Chem 2005,48(4),1256-1259", "ArticleIdList": ["10.1021/jm0493008", "15715493"]}, {"Citation": "Takenaka T.T.; Isolation of nicotianamine from soybean broth and antihypertensive effects in spontaneously hypertensive rats. JOURNAL OF THE BREWING SOCIETY OF JAPAN 2009,104(11),858-865", "ArticleIdList": ["10.6013/jbrewsocjapan.104.858"]}, {"Citation": "Takahashi S.; Yoshiya T.; Yoshizawa-Kumagaye K.; Sugiyama T.; <b>Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soy</b><b>bean </b>. Biomed Res 2015,36(3),219-224", "ArticleIdList": ["10.2220/biomedres.36.219", "26106051"]}, {"Citation": "Yao C.; Xi C.; Hu K.; Gao W.; Cai X.; Qin J.; Lv S.; Du C.; Wei Y.; Inhibition of enterovirus 71 replication and viral 3C protease by quercetin. Virol J 2018,15(1),116", "ArticleIdList": ["10.1186/s12985-018-1023-6", "30064445"]}, {"Citation": "Ryu Y.B.; Jeong H.J.; Kim J.H.; Kim Y.M.; Park J.Y.; Kim D.; Naguyen T.T.H.; Park S.J.; Chang J.S.; Park K.H.; Rho M.C.; Lee W.S.; Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition. Bioorg Med Chem 2010,18(22),7940-7947", "ArticleIdList": ["10.1016/j.bmc.2010.09.035", "20934345"]}, {"Citation": "Nguyen T.T.H.; Woo H.J.; Kang H.K.; Nguyen V.D.; Kim Y.M.; Kim D.W.; Ahn S.A.; Xia Y.; Kim D.; Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris. Biotechnol Lett 2012,34(5),831-838", "ArticleIdList": ["10.1007/s10529-011-0845-8", "22350287"]}, {"Citation": "Park J.Y.; Yuk H.J.; Ryu H.W.; Lim S.H.; Kim K.S.; Park K.H.; Ryu Y.B.; Lee W.S.; Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors. J Enzyme Inhib Med Chem 2017,32(1),504-512", "ArticleIdList": ["10.1080/14756366.2016.1265519", "28112000"]}, {"Citation": "Omrani M.; Keshavarz M.; Nejad Ebrahimi S.; Mehrabi M.; McGaw L.J.; Ali Abdalla M.; Mehrbod P.; Potential natural products against respiratory viruses: A perspective to develop anti-COVID-19 medicines. Front Pharmacol 2021,11,586993", "ArticleIdList": ["10.3389/fphar.2020.586993", "33679384"]}, {"Citation": "Prasansuklab A.; Theerasri A.; Rangsinth P.; Sillapachaiyaporn C.; Chuchawankul S.; Tencomnao T.; Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection. J Tradit Complement Med 2021,11(2),144-157", "ArticleIdList": ["10.1016/j.jtcme.2020.12.001", "33520683"]}, {"Citation": "Cheng P.W.; Ng L.T.; Chiang L.C.; Lin C.C.; Antiviral effects of saikosaponins on human coronavirus 229E in vitro. Clin Exp Pharmacol Physiol 2006,33(7),612-616", "ArticleIdList": ["10.1111/j.1440-1681.2006.04415.x", "16789928"]}, {"Citation": "Lin S.C.; Ho C.T.; Chuo W.H.; Li S.; Wang T.T.; Lin C.C.; Effective inhibition of MERS-CoV infection by resveratrol. BMC Infect Dis 2017,17(1),144", "ArticleIdList": ["10.1186/s12879-017-2253-8", "28193191"]}, {"Citation": "Dai Y.; Chen S.R.; Chai L.; Zhao J.; Wang Y.; Wang Y.; Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolide (sup1), S17-S29.2019,59", "ArticleIdList": ["10.1080/10408398.2018.1501657", "30040451"]}, {"Citation": "Ding Y.; Chen L.; Wu W.; Yang J.; Yang Z.; Liu S.; Andrographolide inhibits influenza A virus-induced inflammation in a murine model through NF-\u03baB and JAK-STAT signaling pathway. Microbes Infect 2017,19(12),605-615", "ArticleIdList": ["10.1016/j.micinf.2017.08.009", "28889969"]}, {"Citation": "Uttekar M.M.; Das T.; Pawar R.S.; Bhandari B.; Menon V.;; Nutan; Gupta, S.K.; Bhat, S.V. Anti-HIV activity of semisynthetic derivatives of andrographolide and computational study of HIV-1 gp120 protein binding. Eur J Med Chem 2012,56,368-374", "ArticleIdList": ["10.1016/j.ejmech.2012.07.030", "22858223"]}, {"Citation": "Wintachai P.; Kaur P.; Lee R.C.H.; Ramphan S.; Kuadkitkan A.; Wikan N.; Ubol S.; Roytrakul S.; Chu J.J.H.; Smith D.R.; Activity of andrographolide against chikungunya virus infection. Sci Rep 2015,5(1),14179", "ArticleIdList": ["10.1038/srep14179", "26384169"]}, {"Citation": "Panraksa P.; Ramphan S.; Khongwichit S.; Smith D.R.; Activity of andrographolide against dengue virus. Antiviral Res 2017,139,69-78", "ArticleIdList": ["10.1016/j.antiviral.2016.12.014", "28034742"]}, {"Citation": "Yu B.; Dai C.; Jiang Z.; Li E.; Chen C.; Wu X.; Chen J.; Liu Q.; Zhao C.; He J.; Ju D.; Chen X.; Andrographolide as an Anti-H1N1 drug and the mechanism related to retinoic acid-inducible gene-I-like receptors signaling pathway. Chin J Integr Med 2014,20(7),540-545", "ArticleIdList": ["10.1007/s11655-014-1860-0", "24972581"]}, {"Citation": "Kim S.; Hwang B.Y.; Su B-N.; Chai H.; Mi Q.; Kinghorn A.D.; Wild R.; Swanson S.M.; Silvestrol, a potential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in LNCaP cells through the mitochondrial/apoptosome pathway without activation of executioner caspase-3 or -7. Anticancer Res 2007,27(4B),2175-2183", "ArticleIdList": ["17695501"]}, {"Citation": "Biedenkopf N.; Lange-Gr\u00fcnweller K.; Schulte F.W.; Wei\u00dfer A.; M\u00fcller C.; Becker D.; Becker S.; Hartmann R.K.; Gr\u00fcnweller A.; The natural compound silvestrol is a potent inhibitor of Ebola virus replication. Antiviral Res 2017,137,76-81", "ArticleIdList": ["10.1016/j.antiviral.2016.11.011", "27864075"]}, {"Citation": "M\u00fcller C.; Schulte F.W.; Lange-Gr\u00fcnweller K.; Obermann W.; Madhugiri R.; Pleschka S.; Ziebuhr J.; Hartmann R.K.; Gr\u00fcnweller A.; Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses. Antiviral Res 2018,150,123-129", "ArticleIdList": ["10.1016/j.antiviral.2017.12.010", "29258862"]}, {"Citation": "Li S.; Chen C.; Zhang H.; Guo H.; Wang H.; Wang L.; Zhang X.; Hua S.; Yu J.; Xiao P.; Li R.S.; Tan X.; Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res 2005,67(1),18-23", "ArticleIdList": ["10.1016/j.antiviral.2005.02.007", "15885816"]}, {"Citation": "Yu M.S.; Lee J.; Lee J.M.; Kim Y.; Chin Y.W.; Jee J.G.; Keum Y.S.; Jeong Y.J.; Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13. Bioorg Med Chem Lett 2012,22(12),4049-4054", "ArticleIdList": ["10.1016/j.bmcl.2012.04.081", "22578462"]}, {"Citation": "Saravanan K.M.; Zhang H.; Senthil R.; Vijayakumar K.K.; Sounderrajan V.; Wei Y.; Shakila H.; Structural basis for the inhibition of SARS-CoV2 main protease by Indian medicinal plant-derived antiviral compounds. J Biomol Struct Dyn 2022,40(5),1970-1978", "ArticleIdList": ["10.1080/07391102.2020.1834457", "33073712"]}, {"Citation": "Wu C.Y.; Jan J.T.; Ma S.H.; Kuo C.J.; Juan H.F.; Cheng Y.S.E.; Hsu H.H.; Huang H.C.; Wu D.; Brik A.; Liang F.S.; Liu R.S.; Fang J.M.; Chen S.T.; Liang P.H.; Wong C.H.; Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc Natl Acad Sci 2004,101(27),10012-10017", "ArticleIdList": ["10.1073/pnas.0403596101", "15226499"]}, {"Citation": "Yi L.; Li Z.; Yuan K.; Qu X.; Chen J.; Wang G.; Zhang H.; Luo H.; Zhu L.; Jiang P.; Chen L.; Shen Y.; Luo M.; Zuo G.; Hu J.; Duan D.; Nie Y.; Shi X.; Wang W.; Han Y.; Li T.; Liu Y.; Ding M.; Deng H.; Xu X.; Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. J Virol 2004,78(20),11334-11339", "ArticleIdList": ["10.1128/JVI.78.20.11334-11339.2004", "15452254"]}, {"Citation": "Chen C.N.; Lin C.P.C.; Huang K.K.; Chen W.C.; Hsieh H.P.; Liang P.H.; Hsu J.T.A.; Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3, 3\u2032-digallate (TF3). Evid Based Complement Alternat Med 2005,2(2),209-215", "ArticleIdList": ["10.1093/ecam/neh081", "15937562"]}, {"Citation": "Paraiso I.L.; Revel J.S.; Stevens J.F.; Potential use of polyphenols in the battle against COVID-19. Curr Opin Food Sci 2020,32,149-155", "ArticleIdList": ["10.1016/j.cofs.2020.08.004", "32923374"]}, {"Citation": "Park J.Y.; Kim J.H.; Kim Y.M.; Jeong H.J.; Kim D.W.; Park K.H.; Kwon H.J.; Park S.J.; Lee W.S.; Ryu Y.B.; Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases. Bioorg Med Chem 2012,20(19),5928-5935", "ArticleIdList": ["10.1016/j.bmc.2012.07.038", "22884354"]}, {"Citation": "Wen C.C.; Kuo Y.H.; Jan J.T.; Liang P.H.; Wang S.Y.; Liu H.G.; Lee C.K.; Chang S.T.; Kuo C.J.; Lee S.S.; Hou C.C.; Hsiao P.W.; Chien S.C.; Shyur L.F.; Yang N.S.; Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J Med Chem 2007,50(17),4087-4095", "ArticleIdList": ["10.1021/jm070295s", "17663539"]}, {"Citation": "Park J.Y.; Kim J.H.; Kwon J.M.; Kwon H.J.; Jeong H.J.; Kim Y.M.; Kim D.; Lee W.S.; Ryu Y.B.; Dieckol, a SARS-CoV 3CLpro inhibitor, isolated from the edible brown algae Ecklonia cava. Bioorg Med Chem 2013,21(13),3730-3737", "ArticleIdList": ["10.1016/j.bmc.2013.04.026", "23647823"]}, {"Citation": "Park J.Y.; Ko J.A.; Kim D.W.; Kim Y.M.; Kwon H.J.; Jeong H.J.; Kim C.Y.; Park K.H.; Lee W.S.; Ryu Y.B.; Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV. J Enzyme Inhib Med Chem 2016,31(1),23-30", "ArticleIdList": ["10.3109/14756366.2014.1003215", "25683083"]}, {"Citation": "Tsai Y.C.; Lee C.L.; Yen H.R.; Chang Y.S.; Lin Y.P.; Huang S.H.; Lin C.W.; Antiviral action of tryptanthrin isolated from Strobilanthes cusia leaf against human coronavirus NL63. Biomolecules 2020,10(3),366", "ArticleIdList": ["10.3390/biom10030366", "32120929"]}, {"Citation": "Kim D.; Min J.; Jang M.; Lee J.; Shin Y.; Park C.; Song J.; Kim H.; Kim S.; Jin Y-H.; Kwon S.; Natural bis-benzyliso-quinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit human coronavirus OC43 infection of MRC-5 human lung cells. Biomolecules 2019,9(11),696", "ArticleIdList": ["10.3390/biom9110696", "31690059"]}, {"Citation": "Cao J.; Forrest J.C.; Zhang X.; A screen of the NIH clinical collection small molecule library identifies potential anti-coronavirus drugs. Antiviral Res 2015,114,1-10", "ArticleIdList": ["10.1016/j.antiviral.2014.11.010", "25451075"]}, {"Citation": "Romero M.; Serrano M.; Efferth T.; Alvarez M.; Marin J.; Effect of cantharidin, cephalotaxine and homoharringtonine on \u201cin vitro\u201d models of hepatitis B virus (HBV) and bovine viral diarrhoea virus (BVDV) replication. Planta Med 2007,73(6),552-558", "ArticleIdList": ["10.1055/s-2007-967184", "17458779"]}, {"Citation": "Zhuang M.; Jiang H.; Suzuki Y.; Li X.; Xiao P.; Tanaka T.; Ling H.; Yang B.; Saitoh H.; Zhang L.; Qin C.; Sugamura K.; Hattori T.; Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection. Antiviral Res 2009,82(1),73-81", "ArticleIdList": ["10.1016/j.antiviral.2009.02.001", "19428598"]}, {"Citation": "Kim D.W.; Seo K.H.; Curtis-Long M.J.; Oh K.Y.; Oh J.W.; Cho J.K.; Lee K.H.; Park K.H.; Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia. J Enzyme Inhib Med Chem 2014,29(1),59-63", "ArticleIdList": ["10.3109/14756366.2012.753591", "23323951"]}, {"Citation": "Zhang D.; Wu K.; Zhang X.; Deng S.; Peng B.; In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. J Integr Med 2020,18(2),152-158", "ArticleIdList": ["10.1016/j.joim.2020.02.005", "32113846"]}, {"Citation": "Tahir ul Qamar, M.; Alqahtani, S.M.; Alamri, M.A.; Chen, L.L. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J Pharm Anal 2020,10(4),313-319", "ArticleIdList": ["10.1016/j.jpha.2020.03.009", "32296570"]}, {"Citation": "Sinha S.K.; Shakya A.; Prasad S.K.; Singh S.; Gurav N.S.; Prasad R.S.; Gurav S.S.; An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets. J Biomol Struct Dyn 2021,39(9),3244-3255", "ArticleIdList": ["32345124"]}, {"Citation": "Vivek-Ananth R.P.; Rana A.; Rajan N.; Biswal H.S.; Samal A.; In silico identification of potential natural product inhibitors of human proteases key to SARS-CoV-2 infection. Molecules 2020,25(17),3822", "ArticleIdList": ["10.3390/molecules25173822", "32842606"]}, {"Citation": "Khaerunnisa S.; Kurniawan H.; Awaluddin R.; Suhartati S.; Soetjipto S.; Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study. Preprints"}, {"Citation": "Wahedi H.M.; Ahmad S.; Abbasi S.W.; Stilbene-based natural compounds as promising drug candidates against COVID-19. J Biomol Struct Dyn 2021,39(9),3225-3234", "ArticleIdList": ["32345140"]}, {"Citation": "Adem S.; Eyupoglu V.; Sarfraz I.; Rasul A.; Ali M.; Identification of potent COVID-19 main protease (Mpro) inhibitors from natural polyphenols: An in silico strategy unveils a hope against corona. 2020"}, {"Citation": "Prasanth D.S.N.B.K.; Murahari M.; Chandramohan V.; Panda S.P.; Atmakuri L.R.; Guntupalli C.; In silico identification of potential inhibitors from Cinnamon against main protease and spike glycoprotein of SARS CoV-2. J Biomol Struct Dyn 2021,39(13),4618-4632", "ArticleIdList": ["10.1080/07391102.2020.1779129", "32567989"]}, {"Citation": "Narkhede R.R.; Pise A.V.; Cheke R.S.; Shinde S.D.; Recognition of natural products as potential inhibitors of COVID-19 main protease (Mpro): In-silico evidences. Nat Prod Bioprospect 2020,10(5),297-306", "ArticleIdList": ["10.1007/s13659-020-00253-1", "32557405"]}, {"Citation": "Aanouz I.; Belhassan A.; El-Khatabi K.; Lakhlifi T.; El-ldrissi M.; Bouachrine M.; Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations. J Biomol Struct Dyn 2021,39(8),2971-2979", "ArticleIdList": ["10.1080/07391102.2020.1758790", "32306860"]}, {"Citation": "Soleymani S.; Zabihollahi R.; Shahbazi S.; Bolhassani A.; Antiviral effects of saffron and its major ingredients. Curr Drug Deliv 2018,15(5),698-704", "ArticleIdList": ["10.2174/1567201814666171129210654", "29189153"]}, {"Citation": "Boff L.; Munkert J.; Ottoni F.M.; Zanchett Schneider N.F.; Ramos G.S.; Kreis W.; Fernandes de Andrade S.; Dias de Souza Filho J.; Braga F.C.; Alves R.J.; Maia de P\u00e1dua R.; Oliveira Sim\u00f5es C.M.; Potential anti-herpes and cytotoxic action of novel semisynthetic digitoxigenin-derivatives. Eur J Med Chem 2019,167,546-561", "ArticleIdList": ["10.1016/j.ejmech.2019.01.076", "30798081"]}, {"Citation": "Astani A.; Reichling J.; Schnitzler P.; Screening for antiviral activities of isolated compounds from essential oils. Evid Based Complement Alternat Med 2011,2011,253643", "ArticleIdList": ["10.1093/ecam/nep187"]}, {"Citation": "Chandra S.; Palai S.; Fagner Ferreira-Matias E.; Cavalcante Pita-Neto I.; Lucas Gomes-Ramalho C.E.R.O.; Martins De Andrade E.; Silva De Almeida R.; Iriti M.; Douglas Melo-Coutinho H.; Indian medicinal plants are effective in the treatment and management of COVID-19. Biocell 2023,47(4),677-695", "ArticleIdList": ["10.32604/biocell.2023.026081"]}, {"Citation": "Kamkin V.; Kamarova A.; Shalabayev B.; Kussainov A.; Anuarbekov M.; Abeuov S.; Comparative analysis of the efficiency of medicinal plants for the treatment and prevention of COVID-19. Int J Biomater 2022,2022,1-14", "ArticleIdList": ["10.1155/2022/5943649", "36536929"]}, {"Citation": "Thakur R.K.; Rajpal V.R.; Raina S.N.; Kumar P.; Sonkar A.; Joshi L.; UPLC-DAD assisted phytochemical quantitation reveals a sex, ploidy and ecogeography specificity in the expression levels of selected secondary metabolites in medicinal tinospora cordifolia: Implications for elites\u2019 identification program. Curr Top Med Chem 2020,20(8),698-709", "ArticleIdList": ["10.2174/1568026620666200124105027", "31976836"]}, {"Citation": "Jain S.K.; Herbal Immunity Boosters Against COVID-19 2022", "ArticleIdList": ["10.2174/97898150794561220101"]}, {"Citation": "Remali J.; Aizat W.M.; A review on plant bioactive compounds and their modes of action against coronavirus infection. Front Pharmacol 2021,11,589044", "ArticleIdList": ["10.3389/fphar.2020.589044", "33519449"]}, {"Citation": "Ackova D.G.; Maksimova V.; Smilko K.; Plant bioactive compounds affecting biomarkers and final outcome of COVID-19. Archives of pharmacy 2022,72,212-230"}, {"Citation": "Khaliq B.; Ali N.; Akrem A.; Ashraf M.Y.; Malik A.; Tahir A.; Zia-Ul-Haq M.; Medicinal plants against COVID-19. The COVID-19 Pandemic 2022,297-337", "ArticleIdList": ["10.1201/9781003283607-12"]}, {"Citation": "Shamna K.; Arthanari M.; Poyil M.; Apple academic pressphytocompounds in the management of COVID-19: A review. Annals of Phytomedicine-an International Journal 2022,30-35"}, {"Citation": "Zhang B.; Qi F.; Herbal medicines exhibit a high affinity for ACE2 in treating COVID-19. Biosci Trends 2023,17(1),14-20", "ArticleIdList": ["10.5582/bst.2022.01534", "36596560"]}, {"Citation": "Abdelgawad S.M.; Hassab M.A.E.; Abourehab M.A.S.; Elkaeed E.B.; Eldehna W.M.; Olive leaves as a potential phytotherapy in the treatment of COVID-19 disease; a mini-review. Front Pharmacol 2022,13,879118", "ArticleIdList": ["10.3389/fphar.2022.879118", "35496299"]}, {"Citation": "Hussain M.; Kr Thakur R.; Khazir J.; Ahmed S.; Khan M.I.; Rahi P.; Peer L.A.; Pragadheesh V.S.; Kaur S.; Raina S.N.; Reshi Z.A.; Traditional uses, phytochemistry, pharmacology, and toxicology of the genus artemisia L.(Asteraceae): A high-value medicinal plant. Current Topics in Medicinal Chemistry 2023,23,142-147"}, {"Citation": "Xiao S.; Liu W.; Bi J.; Liu S.; Zhao H.; Gong N.; Xing D.; Gao H.; Gong M.; Raina S.N.; Anti-inflammatory effect of hesperidin enhances chondrogenesis of human mesenchymal stem cells for cartilage tissue repair. Journal of inflammation 2023,15,1-8"}, {"Citation": "Homayouni F.; Haidari F.; Hedayati M.; Zakerkish M.; Ahmadi K.; Blood pressure lowering and anti\u2010inflammatory effects of hesperidin in type 2 diabetes; a randomized double\u2010blind controlled clinical trial. Phytother Res 2018,32(6),1073-1079", "ArticleIdList": ["10.1002/ptr.6046", "29468764"]}, {"Citation": "Haggag Y.A.; El-Ashmawy N.E.; Okasha K.M.; Is hesperidin essential for prophylaxis and treatment of COVID-19 Infection? Med Hypotheses 2020,144,109957", "ArticleIdList": ["10.1016/j.mehy.2020.109957", "32531538"]}, {"Citation": "Bailly C.; Vergoten G.; Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome? Pharmacol Ther 2020,214,107618", "ArticleIdList": ["10.1016/j.pharmthera.2020.107618", "32592716"]}]}], "History": [{"Year": "2023", "Month": "9", "Day": "28"}, {"Year": "2023", "Month": "12", "Day": "30"}, {"Year": "2024", "Month": "1", "Day": "10"}, {"Year": "2024", "Month": "5", "Day": "30", "Hour": "6", "Minute": "35"}, {"Year": "2024", "Month": "3", "Day": "13", "Hour": "6", "Minute": "46"}, {"Year": "2024", "Month": "3", "Day": "13", "Hour": "5", "Minute": "33"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38477206", "10.2174/0115680266276749240206101847", "CTMC-EPUB-138620"]}}]}